RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 218.0
(1.4%)
SEK 218.0
(1.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 405.93 Million SEK | 19.23% |
| 2022 | 340.84 Million SEK | 72.7% |
| 2021 | 197.36 Million SEK | -7.44% |
| 2020 | 75.82 Million SEK | -15.51% |
| 2019 | 138.3 Million SEK | 21.88% |
| 2018 | 112.97 Million SEK | -9.21% |
| 2017 | 230.82 Million SEK | -14.45% |
| 2016 | 266.93 Million SEK | 83.08% |
| 2015 | 145.61 Million SEK | 8.94% |
| 2014 | 133.67 Million SEK | 375.2% |
| 2013 | 28.13 Million SEK | -60.99% |
| 2012 | 68.6 Million SEK | 150.95% |
| 2011 | 62.96 Million SEK | -28.4% |
| 2010 | 40.12 Million SEK | -2.81% |
| 2009 | 41.28 Million SEK | 70.93% |
| 2008 | 24.15 Million SEK | -14.8% |
| 2007 | 28.35 Million SEK | -30.57% |
| 2006 | 40.85 Million SEK | -9.71% |
| 2005 | 45.29 Million SEK | 200.65% |
| 2004 | 15.04 Million SEK | 67.06% |
| 2003 | 9 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 79.32 Million SEK | 7.67% |
| 2024 Q1 | 114.52 Million SEK | -39.82% |
| 2023 FY | - SEK | 19.23% |
| 2023 Q3 | 28.61 Million SEK | 57.01% |
| 2023 Q2 | 18.22 Million SEK | -23.02% |
| 2023 Q1 | 23.67 Million SEK | 8.56% |
| 2023 Q4 | 122.4 Million SEK | 327.76% |
| 2022 Q4 | 21.8 Million SEK | 81.64% |
| 2022 Q2 | -19.52 Million SEK | -166.05% |
| 2022 Q1 | 29.56 Million SEK | 286.24% |
| 2022 FY | - SEK | 72.7% |
| 2022 Q3 | 12 Million SEK | 161.49% |
| 2021 Q3 | -26.56 Million SEK | -18.24% |
| 2021 FY | - SEK | -7.44% |
| 2021 Q1 | 12.26 Million SEK | 202.96% |
| 2021 Q4 | -15.87 Million SEK | 40.24% |
| 2021 Q2 | -22.46 Million SEK | -283.21% |
| 2020 Q2 | -10.95 Million SEK | -121.25% |
| 2020 Q1 | 51.55 Million SEK | 118.03% |
| 2020 Q4 | -11.9 Million SEK | 59.6% |
| 2020 FY | - SEK | -15.51% |
| 2020 Q3 | -29.47 Million SEK | -169.1% |
| 2019 Q3 | -6.34 Million SEK | -122.02% |
| 2019 Q2 | 28.8 Million SEK | 23.98% |
| 2019 Q4 | 23.64 Million SEK | 472.69% |
| 2019 FY | - SEK | 21.88% |
| 2019 Q1 | 23.23 Million SEK | -74.64% |
| 2018 FY | - SEK | -9.21% |
| 2018 Q4 | 91.64 Million SEK | 85.12% |
| 2018 Q3 | 49.5 Million SEK | 88.54% |
| 2018 Q2 | 26.25 Million SEK | 86.12% |
| 2018 Q1 | 14.1 Million SEK | -85.47% |
| 2017 FY | - SEK | -14.45% |
| 2017 Q1 | 33.46 Million SEK | -66.63% |
| 2017 Q3 | 666 Thousand SEK | -97.52% |
| 2017 Q2 | 26.83 Million SEK | -19.8% |
| 2017 Q4 | 97.08 Million SEK | 14477.63% |
| 2016 Q1 | 23.35 Million SEK | -58.8% |
| 2016 FY | - SEK | 83.08% |
| 2016 Q2 | 37.49 Million SEK | 60.56% |
| 2016 Q3 | 38.46 Million SEK | 2.59% |
| 2016 Q4 | 100.28 Million SEK | 160.71% |
| 2015 FY | - SEK | 8.94% |
| 2015 Q3 | 20.08 Million SEK | 1050.09% |
| 2015 Q4 | 56.67 Million SEK | 182.18% |
| 2015 Q2 | -2.11 Million SEK | -104.53% |
| 2015 Q1 | 46.67 Million SEK | -12.08% |
| 2014 Q2 | 2.14 Million SEK | -65.6% |
| 2014 FY | - SEK | 375.2% |
| 2014 Q4 | 53.08 Million SEK | 191.25% |
| 2014 Q3 | 18.22 Million SEK | 750.84% |
| 2014 Q1 | 6.22 Million SEK | 395.31% |
| 2013 Q4 | 1.25 Million SEK | 108.38% |
| 2013 FY | - SEK | -60.99% |
| 2013 Q3 | -15 Million SEK | 21.98% |
| 2013 Q2 | -19.23 Million SEK | -337.14% |
| 2013 Q1 | 8.11 Million SEK | -69.08% |
| 2012 Q1 | 6.71 Million SEK | -54.12% |
| 2012 Q3 | -446 Thousand SEK | 95.52% |
| 2012 Q2 | -9.95 Million SEK | -248.23% |
| 2012 FY | - SEK | 150.95% |
| 2012 Q4 | 26.23 Million SEK | 5981.61% |
| 2011 Q2 | -119 Thousand SEK | -105.71% |
| 2011 Q3 | 11.01 Million SEK | 9357.98% |
| 2011 Q4 | 14.64 Million SEK | 32.91% |
| 2011 FY | - SEK | -28.4% |
| 2011 Q1 | 2.08 Million SEK | -86.67% |
| 2010 Q4 | 15.62 Million SEK | 2016.94% |
| 2010 FY | - SEK | -2.81% |
| 2010 Q3 | 738 Thousand SEK | -94.11% |
| 2010 Q2 | 12.52 Million SEK | 11.4% |
| 2010 Q1 | 11.24 Million SEK | -53.62% |
| 2009 Q1 | 9.85 Million SEK | 0.0% |
| 2009 Q3 | 445 Thousand SEK | -93.41% |
| 2009 FY | - SEK | 70.93% |
| 2009 Q4 | 24.23 Million SEK | 5346.52% |
| 2009 Q2 | 6.75 Million SEK | -31.44% |
| 2008 FY | - SEK | -14.8% |
| 2007 FY | - SEK | -30.57% |
| 2006 FY | - SEK | -9.71% |
| 2005 FY | - SEK | 200.65% |
| 2004 FY | - SEK | 67.06% |
| 2003 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aino Health AB (publ) | -7.52 Million SEK | 5491.659% |
| Bonzun AB (publ) | -28.58 Million SEK | 1520.121% |
| Kontigo Care AB (publ) | 1.67 Million SEK | -24091.776% |
| Medhelp Care Aktiebolag (publ) | 10 Million SEK | -3958.568% |
| Surgical Science Sweden AB (publ) | 246.9 Million SEK | -64.414% |